Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Latest filing published 23 Jul 2026 for VERTEX PHARMACEUTICALS INC / MA. Read the official filing
Filing timeline
BuySaleAmit Sachdev
Insider track record
Disclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Amit Sachdev: trading record in brief
This profile gathers the share dealings of Amit Sachdev across 2 companies, led by Vertex Pharmaceuticals INC / MA and Eiger BioPharmaceuticals, Inc. Between 2 February 2016 and 21 July 2026, the trades on record add up to 38 filings.
The open-market record consists of 10 sales worth €4.5M, with no purchase. The amount is not disclosed for 4 filings. The rest of the record consists of 25 share grants and 1 option exercise.
Most recently, on 23 July 2026, the filings show a share grant in Vertex Pharmaceuticals INC / MA. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Amit Sachdev
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations38 total
8,251 shares0Common StockSEC:0000875320-26-000251:0
1,518 shares@ US$485.1110.4% of flowCommon StockSEC:0000875320-26-000118:0
23,479 shares@ US$155.5751.7% of flowCommon StockSEC:0000875320-26-000102:0
5,789 shares0Common StockSEC:0000875320-26-000096:0
3,548 shares@ US$487.7624.3% of flowCommon StockSEC:0000875320-26-000074:0
2,057 shares@ US$468.4113.5% of flowCommon StockSEC:0000875320-26-000050:0
7,866 shares0Common StockSEC:0000875320-26-000024:0
3,703 shares@ US$479.619.7% of flowCommon StockSEC:0000875320-25-000133:0
2,470 shares@ US$483.286.5% of flowCommon StockSEC:0000875320-25-000113:0
2,139 shares@ US$463.465.4% of flowCommon StockSEC:0000875320-25-000093:0
6,211 shares0Common StockSEC:0000875320-25-000069:0
2,056 shares@ US$467.985.4% of flowCommon StockSEC:0000875320-25-000046:0
8,210 shares0Common StockSEC:0000875320-25-000022:0
4,600 shares0Common StockSEC:0000875320-24-000172:0
32 shares@ US$430.930.1% of flowCommon StockSEC:0000875320-24-000154:0
2,469 shares@ US$431.795.7% of flowCommon StockSEC:0000875320-24-000107:0
3,191 shares@ US$421.777.2% of flowCommon StockSEC:0000875320-24-000091:0
3,498 shares@ US$424.017.9% of flowCommon StockSEC:0000875320-24-000078:0
2,022 shares@ US$422.744.6% of flowCommon StockSEC:0000875320-24-000053:0
5,814 shares0Common StockSEC:0000875320-24-000030:0
35 shares@ US$369.920.1% of flowCommon StockSEC:0000875320-23-000041:0
10,031 shares@ US$350.0018.4% of flowCommon StockSEC:0000899243-23-018109:0
2,468 shares@ US$289.123.9% of flowCommon StockSEC:0001209191-23-013744:0
3,498 shares@ US$292.855.5% of flowCommon StockSEC:0001209191-23-011699:0
2,611 shares@ US$294.334.1% of flowCommon StockSEC:0001209191-23-009226:0
25 of 38 declarations
